https://www.optimumcomms.com/wp-content/uploads/2023/05/Engimmune_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-23 08:34:032023-06-09 14:49:17Engimmune Therapeutics Announces the Appointment of Dr Annalisa D’Andrea to its Board of Directors
https://www.optimumcomms.com/wp-content/uploads/2023/05/Engimmune_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-23 08:34:032023-06-09 14:49:17Engimmune Therapeutics Announces the Appointment of Dr Annalisa D’Andrea to its Board of Directors
Serca Pharmaceuticals showcases exciting data on 13-M at Heart Failure 2023
First-in-class, cardioprotective drug with potential to transform…

Vicore reports new 36-week data from the AIR trial demonstrating sustained disease stabilization and increase in lung function in IPF patients
Stockholm, May 19, 2023 – Vicore Pharma Holding AB (publ)…

AMSilk to join panel at SynBioBeta Global Synthetic Biology Conference
Munich, Germany, 17 May, 2023: AMSilk GmbH (“AMSilk”), the…

Vicore to host webcast with updated AIR trial results after presentation at the ATS congress
Webcast to be held on: May 26, 2023 at 08:00 EST/14:00 CET
Stockholm,…

Peer-Reviewed Translational Research Paves The Way For First-In-Class Autotaxin Inhibitor IOA-289 In Cancer
Amsterdam, The Netherlands and Geneva, Switzerland, 16 May 2023 -…

Acesion Pharma Announces Positive Pre-Clinical Data for AP31969
Copenhagen, Denmark – Acesion Pharma (“Acesion” or “the…

Vicore strengthens its Board of Directors
Stockholm, May 12, 2023 – Vicore Pharma Holding AB (STO: VICO)…

BII appointed by the Danish government to run international deep tech start-up accelerator
BioInnovation Institute (BII), an international non-profit foundation…

UCB and Ariceum Therapeutics sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer
UCB’s expertise in macrocyclic peptide discovery, using…

STIMULAN® now available in South Africa to treat bacterial infection
Novus Healthcare will exclusively distribute STIMULAN® and genex…

Verona Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update
NDA submission on schedule for Q2 2023
12 abstracts and one…

Neuraxpharm rebrands Laboratorios Lesvi as Neuraxpharm Pharmaceuticals S.L.
Laboratorios Lesvi is Neuraxpharm’s manufacturing facility…

BII-startups pursue US expansion opportunities through TMC BioBridge
Texas Medical Center (TMC) and the BioInnovation Institute (BII)…

iOnctura Expands Pipeline And Receives Development Grant From Health Holland And KWF
Licensing deal gives iOnctura exclusive global development…

Vicore initiates clinical proof-of-concept study of endothelial dysfunction
Stockholm, May 3, 2023 – Vicore Pharma Holding AB (STO:…
We’d love to hear from you
For more information about Optimum Strategic Communications, please get in touch.
Optimum Strategic Communications’ specialist team has an in-depth understanding of how to communicate complex science to investors and corporate stakeholders. Optimum helps life science companies on their journey as they grow and has been trusted by hundreds of healthcare clients from around the world, both public and private, large and small.
Locations
- London
- Amsterdam
- Stockholm
- Zurich
- New York